摘要
目的:观察控制糖化血红蛋白(HbAl c)对早期糖尿病肾病的意义。方法:根据HbAl c水平将Ⅱ型糖尿患者分为三组:HbAl c≤7.0为第1组;7.0≤HbAl c≤10.0为第2组;HbAl c≥10.0为第3组,;同时选取30例体检的健康人作为对照组。测定各组患者尿微量白蛋白(Umal b)及血清甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)、载脂蛋白B(APOB)水平。结果:①1、2、3组与对照组相比Umal b、LDL-C、APOB水平升高且有显著差异性(P<0.05),且1、2、3组之间Umal b、LDL-C、APOB水平有显著差异性(P<0.05);②TG、TC在各组间无明显变化。结论:糖化血红蛋白的严格控制能延缓Ⅱ型糖尿患者的早期糖尿病肾病的发生及发展。
Objective To observe the effects of the control of HbAIc on patients with primary diabetic nephroma. Methods Four groups were randomly selected: the first group (HbAIc≤7.0. n=30),the second group (7.0≤HbAIc≤10.0. n=30), the third group (HbAIc≥ 10.0, n=30), the control group(C group, n=30).The levels of Umalb,TG,TC,LDL-C,APOB were detected. Results (1)The lev- els of Umalb,LDL-C,APOB were higher in group of 1,2,3 than control group and the differences of levels of Umalb,TG,TC,LDL-C, APOB among 1,2,3 group were significant. (P〈0.05); (2) The levels of TG,TC were not different (P〉0.05) .Conclusion The control of HbAIc play important roles in patients with primary diabetic nephroma.
出处
《中国美容医学》
CAS
2012年第08X期98-99,共2页
Chinese Journal of Aesthetic Medicine